Click

Below is a selected list of timely federal funding opportunities that are relevant to the osteopathic medical education community. AACOM updates this resource frequently.  Please bookmark the page for your reference. For a comprehensive listing of federal funding opportunities, please visit Grants.gov.   

Featured Opportunities

September 6 – September 12

National Institutes of Health

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)

Letter of Intent Due: 30 days prior to the application due date

Application Due: November 14, 2018, by 5:00 PM local time of applicant organization

The National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs).

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Letter of Intent Due: 30 days prior to the application due date

Application Due: February 11, 2019, by 5:00 PM local time of applicant organization

This opportunity will advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp- Clinical Trial Not Allowed)

Application Due: November 5, 2018, by 5:00 PM local time of applicant organization

This opportunity will allow investigators to expand upon and explore new opportunities within the broad scope of a currently funded, peer-reviewed research project to facilitate the transition from a single project to a research program.

Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)

Application Due: February 16, 2018, by 5:00 PM local time of applicant organization

This opportunity will facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs, to enable the conduct of small "proof of concept" studies.

Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)

Letter of Intent Due: January 4, 2019

Application Due: February 4, 2019, by 5:00 PM local time of applicant organization

This opportunity will support the development of a Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center that will organize activities and provide research resources for clinician-investigators across the United States who are focusing their careers on aging research.

Health Resources and Services Administration

Health Center Program’s Service Area Competition (SAC)

Application Due: November 6, 2018

This opportunity will ensure continued access to affordable, quality primary health care services for communities and vulnerable populations currently served by the Health Center Program.


August 30 – September 5

National Institutes of Health

Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)

Letter of Intent Due: 30 days prior to the application due date

Application Due: December 3, 2018, by 5:00 PM local time of applicant organization

This opportunity will use the R01 mechanism to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts among fundamental (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers in the environmental health field.

Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed)

Letter of Intent Due: 30 days prior to the application due date   

Application Due: October 31, 2018, by 5:00 PM local time of applicant organization

This opportunity invites pre-applications for projects that test new therapeutic uses for experimental drugs or biologics (Assets) across a broad range of human diseases in adult and pediatric populations.